Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First
Overview
Affiliations
Structures of peptide-loaded major histocompatibility complex class I (pMHC-I) and class II (pMHC-II) complexes are similar. However, whereas pMHC-II complexes include similar-sized IIα and IIβ chains, pMHC-I complexes include a heavy chain (HC) and a single domain molecule β-microglobulin (β-m). Recently, we elucidated several pMHC-I and pMHC-II structures of primitive vertebrate species. In the present study, a comprehensive comparison of pMHC-I and pMHC-II structures helps to understand pMHC structural evolution and supports the earlier proposed-though debated-direction of MHC evolution from class II-type to class I. Extant pMHC-II structures share major functional characteristics with a deduced MHC-II-type homodimer ancestor. Evolutionary establishment of pMHC-I presumably involved important new functions such as (i) increased peptide selectivity by binding the peptides in a closed groove (ii), structural amplification of peptide ligand sequence differences by binding in a non-relaxed fashion, and (iii) increased peptide selectivity by syngeneic heterotrimer complex formation between peptide, HC, and β-m. These new functions were associated with structures that since their establishment in early pMHC-I have been very well conserved, including a shifted and reorganized P1 pocket (aka A pocket), and insertion of a β-m hydrophobic knob into the peptide binding domain β-sheet floor. A comparison between divergent species indicates better sequence conservation of peptide binding domains among MHC-I than among MHC-II, agreeing with more demanding interactions within pMHC-I complexes. In lungfishes, genes encoding fusions of all MHC-IIα and MHC-IIβ extracellular domains were identified, and although these lungfish genes presumably derived from classical MHC-II, they provide an alternative mechanistic hypothesis for how evolution from class II-type to class I may have occurred.
MMPred: a tool to predict peptide mimicry events in MHC class II recognition.
Guerri F, Junet V, Farres J, Daura X Front Genet. 2024; 15:1500684.
PMID: 39722794 PMC: 11669352. DOI: 10.3389/fgene.2024.1500684.
Molina-Alejandre M, Perea F, Calvo V, Martinez-Toledo C, Nadal E, Sierra-Rodero B J Immunother Cancer. 2024; 12(10).
PMID: 39428126 PMC: 11492944. DOI: 10.1136/jitc-2024-009762.
Vaulin A, Karpulevich E, Kasianov A, Morozova I Sci Rep. 2024; 14(1):21816.
PMID: 39294244 PMC: 11410964. DOI: 10.1038/s41598-024-71803-7.
Meng X, Chi H, Zhang Z, Li Q, Sheng X, Tang X Vaccines (Basel). 2023; 11(10).
PMID: 37897005 PMC: 10611026. DOI: 10.3390/vaccines11101603.
Antibody Cross-Reactivity in Auto-Immune Diseases.
Trier N, Houen G Int J Mol Sci. 2023; 24(17).
PMID: 37686415 PMC: 10487534. DOI: 10.3390/ijms241713609.